Statins 'could benefit the healthy'

 

Cholesterol-lowering drugs can benefit even apparently healthy people with no previous history of heart disease, a study has found.

The findings suggest everyone over a certain age should qualify for statin therapy, say experts.

Many doctors already take the pills, which lower levels of cholesterol in the blood.

But NHS prescriptions of the drugs are restricted to patients judged to have at least a 20 per cent risk of a "major vascular event" in the next 10 years.

A major vascular event can include a non-fatal heart attack, stroke, or surgery to bypass or unblock damaged arteries.

The authors of the new research say the findings suggest international treatment guidelines for statins should be reconsidered.

To conduct the "meta-analysis" study, they pooled together data on 175,000 patients who took part in 27 separate randomised trials.

Participants were grouped into one of five categories of five-year major vascular event risk.

Statins were found to reduce the risk of serious vascular events by more than a fifth (21 per cent) for each unit reduction in levels of harmful cholesterol.

The pattern was repeated in each of the five groups studied, including those people at lowest risk.

In individuals where the five-year chance of a major event was less than 10 per cent, the already small risk was significantly lowered, even in people with no history of vascular disease.

This was mainly due to reduced numbers of heart attacks and surgical operations.

The findings appear in the latest online edition of The Lancet medical journal.

Researchers measured millimoles per litre (mmol/L) reductions of "bad" low density lipoprotein (LDL) cholesterol in the blood.

They found that every one mmol/L lowering of LDL cholesterol reduced the risk of major vascular events by 21 per cent "irrespective of age, sex, baseline LDL cholesterol or previous vascular disease, and of vascular and all-cause mortality".

In people with a five-year risk of major vascular events lower than 10 per cent, each unit lowering of LDL cholesterol reduced event incidence by about 11 per 1,000 individuals over five years.

The authors, led by Professor Colin Baigent, from Oxford University, wrote: "This benefit greatly exceeds any known hazards of statin therapy.

"Under present guidelines, such individuals would not typically be regarded as suitable for LDL-lowering statin therapy. The present report suggests, therefore, that these guidelines might need to be reconsidered."

The research found no evidence that statins increased cancer incidence or deaths from non-vascular causes.

In an accompanying article, two UK experts said more affordable ways of identifying patients suitable for statins were needed.

Professor Shah Ebrahim and Dr Juan Casas, both from the London School of Hygiene and Tropical Medicine, wrote: "Because most people older than 50 years are likely to be at a greater than 10 per cent 10-year risk of CVD (cardio-vascular disease), it would be more pragmatic to use age as the only indicator of statin prescription.

"This approach would avoid the costs, ranging from £7 to more than £700 per patient screened, of vascular screening checks recently implemented in the UK."

June Davison, senior cardiac nurse at the British Heart Foundation, which part-funded the study, said: "Those who already have heart disease, or are at high risk, are offered statins because it's well established they help to lower cholesterol and reduce the risk of heart disease.

"This large-scale research found even people at low risk of heart disease could benefit from statin therapy. The findings will help to inform policy and treatment guidelines in the future."

Other research published in The Lancet challenges the widely-held view that raising levels of "good" cholesterol can reduce the risk of heart attacks.

Scientists looked at heart attack rates in people with naturally higher levels of high-density lipoprotein (HDL) cholesterol.

Analysis of data from 20 studies involving more than 100,000 people found no evidence that elevated HDL reduced the chances of having a heart attack.

Lead author Dr Sekar Kathiresan, from Harvard Medical School in the US, said: "If an intervention such as a drug raises HDL cholesterol, we cannot automatically assume that risk of myocardial infarction (heart attack) will be reduced."

A Department of Health spokesman said: "We keep all new research under consideration. Nice (National Institute for health and Clinical Excellence, which assesses the cost effectiveness of NHS treatments) regularly reviews its published guidance in order to take account of new evidence."

PA

ebooks
ebookA delicious collection of 50 meaty main courses
Life and Style
ebookNow available in paperback
News
i100
Arts and Entertainment
Billie Piper as Brona in Penny Dreadful
tvReview: It’s business as usual in Victorian London. Let’s hope that changes as we get further into the new series spoiler alert
Life and Style
A nurse tends to a recovering patient on a general ward at The Queen Elizabeth Hospital in Birmingham
health
News
science
Arts and Entertainment
No Offence
tvReview: No Offence has characters who are larger than life and yet somehow completely true to life at the same time spoiler alert
News
Chuck Norris pictured in 1996
people
Arts and Entertainment
Sarah Lucas, I SCREAM DADDIO, Installation View, British Pavilion 2015
artWhy Sarah Lucas is the perfect choice to represent British art at the Venice Biennale
News
A voter placing a ballot paper in the box at a polling station
i100
News
people
Arts and Entertainment
The Queen (Kristin Scott Thomas) in The Audience
theatreReview: Stephen Daldry's direction is crisp in perfectly-timed revival
Sport
football
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    SThree: Trainee Recruitment Consultant - Dublin

    £13676.46 - £16411.61 per annum + OTE: SThree: SThree Trainee Recruitment Cons...

    Ashdown Group: Marketing or Business Graduate Opportunity - Norwich - £22,000

    £18000 - £22000 per annum + training: Ashdown Group: Business and Marketing Gr...

    SThree: Trainee Recruitment Consultant

    £20000 - £25000 per annum + Commission: SThree: Are you great at building rela...

    Ashdown Group: Database Analyst - Birmingham - £22,000 plus benefits

    £20000 - £22000 per annum + excellent benefits: Ashdown Group: Application Sup...

    Day In a Page

    General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

    Miliband's unlikely journey from hapless geek to heart-throb

    He was meant to be Labour's biggest handicap - but has become almost an asset
    General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

    On the margins

    From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
    Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

    'This is the battle of young Egypt for the future of our country'

    Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
    Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

    Why patients must rely less on doctors

    Improving our own health is the 'blockbuster drug of the century'
    Sarah Lucas is the perfect artist to represent Britain at the Venice Biennale

    Flesh in Venice

    Sarah Lucas has filled the British pavilion at the Venice Biennale with slinky cats and casts of her female friends' private parts. It makes you proud to be a woman, says Karen Wright
    11 best anti-ageing day creams

    11 best anti-ageing day creams

    Slow down the ageing process with one of these high-performance, hardworking anti-agers
    Juventus 2 Real Madrid 1: Five things we learnt, including Iker Casillas is past it and Carlos Tevez remains effective

    Juventus vs Real Madrid

    Five things we learnt from the Italian's Champions League first leg win over the Spanish giants
    Ashes 2015: Test series looks a lost cause for England... whoever takes over as ECB director of cricket

    Ashes series looks a lost cause for England...

    Whoever takes over as ECB director of cricket, says Stephen Brenkley
    Fishing for votes with Nigel Farage: The Ukip leader shows how he can work an audience as he casts his line to the disaffected of Grimsby

    Fishing is on Nigel Farage's mind

    Ukip leader casts a line to the disaffected
    Who is bombing whom in the Middle East? It's amazing they don't all hit each other

    Who is bombing whom in the Middle East?

    Robert Fisk untangles the countries and factions
    China's influence on fashion: At the top of the game both creatively and commercially

    China's influence on fashion

    At the top of the game both creatively and commercially
    Lord O’Donnell: Former cabinet secretary on the election and life away from the levers of power

    The man known as GOD has a reputation for getting the job done

    Lord O'Donnell's three principles of rule
    Rainbow shades: It's all bright on the night

    Rainbow shades

    It's all bright on the night
    'It was first time I had ever tasted chocolate. I kept a piece, and when Amsterdam was liberated, I gave it to the first Allied soldier I saw'

    Bread from heaven

    Dutch survivors thank RAF for World War II drop that saved millions
    Britain will be 'run for the wealthy and powerful' if Tories retain power - Labour

    How 'the Axe' helped Labour

    UK will be 'run for the wealthy and powerful' if Tories retain power